NO20052979L - Propargyl-trifluormetoksy-amino-benzotiazolderivater. - Google Patents
Propargyl-trifluormetoksy-amino-benzotiazolderivater.Info
- Publication number
- NO20052979L NO20052979L NO20052979A NO20052979A NO20052979L NO 20052979 L NO20052979 L NO 20052979L NO 20052979 A NO20052979 A NO 20052979A NO 20052979 A NO20052979 A NO 20052979A NO 20052979 L NO20052979 L NO 20052979L
- Authority
- NO
- Norway
- Prior art keywords
- present
- alkyl
- integer
- propargyl
- benzothiazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
hvori Ri er til stede eller fraværende, og når tilstede er H, C1-C6 alkyl, C1-C6 alkynyl, -(CH2)yS(CH2)xCH3, Ci-C6 aminoalkyl, Ci-C6 hydroksyalkyl eller -CCH2)nC(=O) (C6H4) (CH2)R2; R2 er H eller C1-C4 alkyl; R3 er H eller C1-C4 alkyl; R4 er til stede eller fraværende, og når tilstede er H, C1-C6 alkyl, C1-C6 alkynyl, -(CH2)yS(CH2)xCH3, Ci-C6 aminoalkyl, d-C6 hydroksyalkyl eller -(CH2)nC(=O)(C6H4)(CH2)R2; hvori n er et heltall på fra 1 -6; hvori x er 0 er et heltall på fra 1 -5 og y er et heltall på 1-5, slik at x+y<6; minst en av Ri eller R4 er til stede; den stiplede linjen representerer en binding mellom et av nitrogenatomene og det intervenerende karbonatomet; og en hvilken som helst forbindelse er ladet når både Ri og R4 er til stede, eller en hvilken som helst spesifikk enantiomer derav eller et hvilket som helst farmasøytisk akseptabelt salt derav, og en fremgangsmåte for behandling av en neurologisk forstyrrelse eller multiple sklerose ved administrasjon av en terapeutisk effektiv mengde av en hvilken som helst av forbindelsene.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30154002A | 2002-11-21 | 2002-11-21 | |
| PCT/US2003/037592 WO2004047756A2 (en) | 2002-11-21 | 2003-11-20 | Propargyl-trifluoromethoxy-amino-benzothiazole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052979D0 NO20052979D0 (no) | 2005-06-17 |
| NO20052979L true NO20052979L (no) | 2005-08-19 |
Family
ID=32392394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052979A NO20052979L (no) | 2002-11-21 | 2005-06-17 | Propargyl-trifluormetoksy-amino-benzotiazolderivater. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1569641A2 (no) |
| JP (1) | JP2006507350A (no) |
| KR (1) | KR20050083951A (no) |
| CN (1) | CN1741802A (no) |
| AU (1) | AU2003295898A1 (no) |
| BR (1) | BR0315704A (no) |
| CA (1) | CA2507414A1 (no) |
| IS (1) | IS7906A (no) |
| MX (1) | MXPA05005414A (no) |
| NO (1) | NO20052979L (no) |
| RU (1) | RU2005119307A (no) |
| WO (1) | WO2004047756A2 (no) |
| ZA (1) | ZA200504988B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2621490A4 (en) | 2010-09-29 | 2014-04-02 | Teva Pharma | PROPARGYL-TRIFLUOROMETHOXY-AMINO-BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF |
| CN103340859A (zh) * | 2013-06-04 | 2013-10-09 | 中国科学院昆明动物研究所 | 侧脑室mpp+给药建立非人灵长类帕金森病动物模型的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59112978A (ja) * | 1982-12-21 | 1984-06-29 | Shionogi & Co Ltd | プロピニルアミノチアゾ−ル誘導体 |
-
2003
- 2003-11-20 WO PCT/US2003/037592 patent/WO2004047756A2/en not_active Application Discontinuation
- 2003-11-20 AU AU2003295898A patent/AU2003295898A1/en not_active Abandoned
- 2003-11-20 KR KR1020057009216A patent/KR20050083951A/ko not_active Application Discontinuation
- 2003-11-20 ZA ZA200504988A patent/ZA200504988B/en unknown
- 2003-11-20 CN CNA2003801090823A patent/CN1741802A/zh active Pending
- 2003-11-20 BR BR0315704-0A patent/BR0315704A/pt not_active Application Discontinuation
- 2003-11-20 MX MXPA05005414A patent/MXPA05005414A/es not_active Application Discontinuation
- 2003-11-20 CA CA002507414A patent/CA2507414A1/en not_active Abandoned
- 2003-11-20 JP JP2004555702A patent/JP2006507350A/ja active Pending
- 2003-11-20 EP EP03787112A patent/EP1569641A2/en not_active Withdrawn
- 2003-11-20 RU RU2005119307/04A patent/RU2005119307A/ru not_active Application Discontinuation
-
2005
- 2005-06-17 NO NO20052979A patent/NO20052979L/no not_active Application Discontinuation
- 2005-06-22 IS IS7906A patent/IS7906A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IS7906A (is) | 2005-06-22 |
| ZA200504988B (en) | 2006-08-30 |
| MXPA05005414A (es) | 2006-05-25 |
| NO20052979D0 (no) | 2005-06-17 |
| CN1741802A (zh) | 2006-03-01 |
| BR0315704A (pt) | 2005-09-06 |
| EP1569641A2 (en) | 2005-09-07 |
| CA2507414A1 (en) | 2004-06-10 |
| RU2005119307A (ru) | 2006-01-27 |
| WO2004047756A2 (en) | 2004-06-10 |
| AU2003295898A1 (en) | 2004-06-18 |
| KR20050083951A (ko) | 2005-08-26 |
| JP2006507350A (ja) | 2006-03-02 |
| WO2004047756A3 (en) | 2004-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0000167A2 (hu) | Pirrolvegyületek, és ezeket a vegyületeket tartalmazó spla2-inhibitor hatású gyógyszerészeti készítmények | |
| HUP0302893A2 (hu) | Nem-imidazol ariloxipiperidinek és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0102471A2 (hu) | 4-Benzil-piperidin alkilszulfoxid heterociklusok és használatuk altípus-szelektív NMDA antagonistaként és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0202381A2 (hu) | MEK-inhibitor hatású fenil-amino-benzoesav-származékok alkalmazása krónikus fájdalom kezelésére szolgáló gyógyszerkészítmények előállítására | |
| IL154272A (en) | Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands | |
| DE69931393D1 (de) | Antithrombotische amide | |
| HK1062677A1 (en) | 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| HUP0400365A2 (hu) | 3-Fluor-pirrolidinek, mint cukorbetegség elleni szerek és a vegyületeket tartalmazó gyógyszerkészítmények | |
| TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
| HUP0301625A2 (hu) | Réztartalmú amin-oxidáz inhibitor hatású 1,3,4-oxadiazin-vegyületek, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására | |
| HUP0401086A2 (hu) | 4-[(Fenil-piperazinil)-metil]-benzamid-származékok és alkalmazásuk fájdalom, szorongás vagy gasztrointesztinális zavarok kezelésére szolgáló gyógyszerkészítmények előállítására és eljárás a vegyületek előállítására | |
| TW427887B (en) | Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections | |
| NO20060428L (no) | 2-amino-bicyklo[3.1.0]heksan-2,6-dikarboksylesterderivat | |
| HUP9900851A2 (hu) | Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására | |
| HUP0102255A2 (hu) | VLA-4 inhibitor hatású oMePUPA-V, ezt tartalmazó gyógyszerkészítmény és alkalmazása | |
| MXPA02001571A (es) | Metodo de tratamiento para el cancer. | |
| HUP9801946A2 (hu) | 5-HT-felvétel-inhibitorból és szelektív 5-H1A-antagonistából álló kombinációs gyógyászati készítmény és eljárás előállítására | |
| NZ331801A (en) | Therapeutic agent for diabetes | |
| IL108695A (en) | Pharmaceutical composition comprising polyamine derivatives and some such novel compounds | |
| SI1511496T1 (sl) | Metoda zdravljenja ali prevencije imunsko mediiranih motenj in farmacevtska formulacija za njeno uporabo | |
| NO20052979L (no) | Propargyl-trifluormetoksy-amino-benzotiazolderivater. | |
| MA27257A1 (fr) | Composes utiles pour le traitement du charbon et l'inhibition du gene letal | |
| SG146681A1 (en) | 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) | |
| TW200633710A (en) | Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor | |
| HUP9901212A2 (hu) | N,N-dialkil-N-[2-(3-alkoxi-fenoxi)-etil]-amin-származékok, az ezeket tartalmazó gyógyszerkészítmények és helyi érzéstelenítőkként való alkalmazásuk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |